{
    "id": "0607",
    "question": "A group of researchers from Italy conducted a case register study that included all patients from a city who had an International Classification of Diseases diagnosis and contacts with specialist psychiatric services over a 10-year period. Mortality was studied in relation to age, sex, diagnosis, care pattern, and registration interval. Standardized mortality ratios (SMRs) were calculated, with the overall SMR being 1.63 (lower when compared with studies that looked at hospitalized individuals). Men and those in younger age groups showed higher mortality rates (SMRs of 2.24 and 8.82, respectively), and mortality was also higher in the first year following registration (SMR = 2.32). Higher mortality was also found in patients with a diagnosis of alcohol and drug dependence (SMR = 3.87). The authors concluded that the overall mortality of psychiatric patients managed in a community-based setting was higher than expected; however, it was still lower than the mortality described in other psychiatric settings. The primary measure used in this study can be defined as which of the following?",
    "options": {
        "A": "The total number of deaths divided by the mid-year population",
        "B": "The number of deaths in a specific age group divided by a mid-year population in that age group",
        "C": "The observed number of deaths divided by the expected number of deaths",
        "D": "The number of deaths from a certain disease in 1 year divided by the total number of deaths in 1 year"
    },
    "answer": "C",
    "predict": "Here's my step-by-step thinking and the answer in JSON format: Step 1: Understand the context of the question - The question is asking about the primary measure used in the case register study mentioned in the passage to calculate mortality rates. Step 2: Review the passage to identify the key phrase that defines the primary measure. The phrase \"Standardized mortality ratios (SMRs) were calculated, with the overall SMR being 1.63\" is the key phrase. Step 3: Analyze the definition of SMR. SMR is a statistical measure that compares the number of observed deaths to the number of expected deaths, taking into account the population at risk. Step 4: Match the definition of SMR with the options provided. Option C, \"The observed number of deaths divided by the expected number of deaths\", is the closest match to the definition of SMR. Step 5: Select the correct answer based on the analysis. JSON output: {\"step_by_step_thinking\": \"The primary measure used in the case register study to calculate mortality rates is the ratio of observed deaths to expected deaths, which is defined as the observed number of deaths divided by the expected number of deaths.\", \"answer_choice\": \"C\"}",
    "snippets": [
        {
            "id": "InternalMed_Harrison_469",
            "title": "InternalMed_Harrison",
            "content": "FIgURE 6e-3 Hospital mortality rates in men and women for acute myocardial infarction (MI) in 1994\u20131995 compared with 2004\u20132006. Women younger than age 65 years had substantially greater mortality than men of similar age in 1994\u20131995. Mortality rates declined markedly for both sexes across all age groups in 2004\u20132006 compared with 1994\u20131995. However, there was a more striking decrease in mortality in women younger than age 75 years compared with men of similar age. The mortality rate reduction was largest in women less than age 55 years (52.9%) and lowest in men of similar age (33.3%). (Data adapted from V Vaccarino et al: Arch Intern Med 169:1767, 2009.) smaller body size, and more severe CHD in women at the time of 6e-3 events or procedures account in part for the observed sex differences."
        },
        {
            "id": "InternalMed_Harrison_27466",
            "title": "InternalMed_Harrison",
            "content": "The high rates of mortality and morbidities observed in AAS users are alarming. One Finnish study reported 4.6 times the risk of death among elite power lifters than in age-matched men from the general population. The causes of death among power lifters included suicides, myocardial infarction, hepatic coma, and non-Hodgkin\u2019s lymphoma. A retrospective review of patient records in Sweden also reported higher standardized mortality ratios for AAS users than for nonusers. Thiblin and colleagues found that 32% of deaths among AAS users were suicidal, 26% homicidal, and 35% accidental. The median age of death among AAS users (24 years) is even lower than that for heroin or amphetamine users."
        },
        {
            "id": "Surgery_Schwartz_7872",
            "title": "Surgery_Schwartz",
            "content": "matched to 7462 control patients. The primary outcome was all-cause mortality. In this study, surgical patients (n = 2500) had a mean age of 52 years and a mean BMI of 47. Matched control patients (n = 7462) had a mean age of 53 years and a mean BMI of 46. At the end of the 14-year study period, there were a total of 263 deaths in the surgical group (mean follow-up, 6.9 years) and 1277 deaths in the matched control group (mean follow-up, 6.6 years). Mor-tality rates were 2.4% at 1 year, 6.4% at 5 years, and 13.8% at 10 years for surgical patients; for matched control patients, 1.7% at 1 year, 10.4% at 5 years, and 23.9% at 10 years. So, in this later study, there was significantly lower all-cause mortal-ity at longer follow-up. 207Ten-year weight change in 1787 veterans who underwent RYGB compared to controls, and separately, 4-year weight change in veterans who underwent RYGB (n = 1785), SG (n = 379), and AGB (n = 246) were reported. Patients undergo-ing RYGB lost 21% more of their"
        },
        {
            "id": "Surgery_Schwartz_7868",
            "title": "Surgery_Schwartz",
            "content": "primary endpoint of the study) from any cause compared to usual care, with the most common causes of death being cancer and myocardial infarction196-201 (see Table 27-6).Utah Obesity Studies. Another important long-term obser-vational study performed in Utah from 1984 to 2002 included 7925 people who had undergone RYGB and 7925 weight, age, and sex matched controls. This study showed a 40% reduction in all-cause mortality (hazard ratio 0.60, 0.45 to 0.67; P <0.001) and a 49% (0.51, 0.36 to 0.73; P <0.001) and 92% (0.08, 0.01 to 0.47; P = 0.005) reduction in death from cardiovascular disease and death related to T2DM, respectively, at an average of 7.1 years later.202A separate ongoing prospective Utah Obesity Study involving over 400 RYGB cases and two nonrandomized, matched control groups\u2014each with over 400 and 300 severely obese subjects (one group were people seeking surgery that did not undergo operation; the other was a population-based severely obese control group)\u2014has found"
        },
        {
            "id": "Surgery_Schwartz_7928",
            "title": "Surgery_Schwartz",
            "content": "in the second postoperative year (9.6%) in those undergoing RYGB compared to before surgery (7.6%). Risk factors for alcohol use disorders included male gender, younger age, and preoperative smoking or alcohol use.271 At 7-year follow-up in LABS, there was a progressive and sig-nificant increase over time in the prevalence of regular alcohol consumption for both RYGB and LAGB. In addition, alcohol use disorders, illicit drug use, and treatment for substance use disorders, increased over the 7-year period for RYGB only.272 Overall, these rates were high, with 20% of RYGB participants reporting incident alcohol use disorder symptoms within 5 years of surgery.In addition, there may be an increased risk for suicide273-275 following bariatric surgery, although the etiology is unclear and the data is varied and complex to interpret.276 The Utah mortality study showed a 58% increase in all non\u2013disease-related causes of death in the RYGB group compared to the matched control population,"
        },
        {
            "id": "Psichiatry_DSM-5_189",
            "title": "Psichiatry_DSM-5",
            "content": "Health Statistics to ensure consistent international recording of prevalence and mortality rates for identified health conditions. For most clinicians, the codes are used to identify the diagnosis or reason for visit for CMS and private insurance service claims. The official coding system in use in the United States as of publication of this manual is ICD-9-CM. Of- ficial adoption of ICD-lO-CM is scheduled to take place on October 1, 2014, and these codes, which are shown parenthetically in this manual, should not be used until the offi- cial implementation occurs. Both ICD-9-CM and ICD-IO\u2014CM codes have been listed 1) pre- ceding the name of the disorder in the classification and 2) accompanying the criteria set for each disorder. For some diagnoses (e.g., neurocognitive and substance/medication- induced disorders), the appropriate code depends on further specification and is listed within the criteria set for the disorder, as coding notes, and, in some cases, further clarified in a"
        },
        {
            "id": "Psichiatry_DSM-5_2421",
            "title": "Psichiatry_DSM-5",
            "content": "Course modifiers. In general, high levels of impulsivity are associated with an earlier onset and more severe alcohol use disorder. In most cultures, alcohol is the most frequently used intoxicating substance and contrib- utes to considerable morbidity and mortality. An estimated 3.8% of all global deaths and 4.6% of global disability\u2014adjusted life-years are attributable to alcohol. In the United States, 80% of adults (age 18 years and older) have consumed alcohol at some time in their lives, and 65% are current drinkers (last 12 months). An estimated 3.6% of the world population (15\u201464 years old) has a current (12-month) alcohol use disorder, with a lower prevalence (1.1%) found in the African region, a higher rate (5.2%) found in the American region (North, South, and Central America and the Caribbean), and the highest rate (10.9%) found in the Eastern Europe region."
        },
        {
            "id": "Surgery_Schwartz_6197",
            "title": "Surgery_Schwartz",
            "content": "in the endolu-minal group. There was no difference in the nonvascular local complication rate among the two groups. The Endovascular Repair-1 (EVAR-1) trial is also a multicenter randomized trial that compared open to endoluminal repair.67 This study was con-ducted on 1082 patients at 34 centers in the United Kingdom using all available devices. Short-term mortality at 30 days was 4.7% in the open group and 1.7% in the endoluminal group. The in-hospital mortality rate was also increased in the open when compared to the endoluminal group (6.2% vs. 2.1%). As expected, the secondary intervention rate was higher in the endoluminal group (9.8% vs. 5.8%). Complication rates were not reported in the EVAR-1 trial. Criticisms can be applied to both of these trials. Patients had to be eligible for either type of repair in order to be included in the study. Consequently, these findings cannot be generalized to patients who are too sick to undergo open surgery or to patients whose anatomy"
        },
        {
            "id": "InternalMed_Harrison_5512",
            "title": "InternalMed_Harrison",
            "content": "of data sources to provide estimates of the global burden of disease at the beginning of this century, with projections to future years based on recent trends in disease prevalence and demographic rates. Burden of disease in these pie charts is a composite measure, one that takes into account both the number of deaths due to a particular disease or condition and the timing of such deaths\u2014an infant death represents a loss of more potential life-years lived than does the death of a very old person. Nor is death the only outcome that matters; most diseases or conditions cause significant disability and suffering even when nonfatal, so this measure of burden captures nonfatal outcomes using statistical weighting. As Table 93e-3 shows, the \u201cmodern plagues\u201d of chronic noncommunicable diseases are already among the leading causes of premature death and disability even in low-income countries. This is due to a mix of factors\u2014lower fertility rates mean fewer infants and children at prime ages"
        },
        {
            "id": "InternalMed_Harrison_1132",
            "title": "InternalMed_Harrison",
            "content": "FIgURE 16e-1 Age-adjusted death rates for selected causes by race and Hispanic origin, 2005. (From the U.S. Census Bureau, 2009.) 81.5 80 76.9 76.8 75.8 74.2 73.3 69.5 74.6 68.7 66.2 FIgURE 16e-2 Recommended hospital care received by Medicare patients with pneumonia, by race/ethnicity, 2006. The reference population consisted of Medicare beneficiaries with pneumonia who were hospitalized. The composite was calculated by averaging the percentage of the population that received each of the five incorporated components of care. (Adapted from Agency for Healthcare Research and Quality: The 2008 National Health Care Disparities Report.)"
        },
        {
            "id": "InternalMed_Harrison_458",
            "title": "InternalMed_Harrison",
            "content": "Deaths anD perCentage of totaL Deaths for the LeaDing Causes of Death By sex in the uniteD states in 2010 Cause of Death Rank Deaths Deaths, % Rank Deaths Deaths, % Note: Category titles beginning with \u201cother\u201d or \u201call other\u201d are not ranked when determining the leading causes of death. Source: Data from Centers for Disease Control and Prevention: National Vital Statistics Reports, Vol. 61, No. 4, May 8, 2013, Table 12, http://www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61_04.pdf. Rates per 100,000 Rates per 100,000 20\u201324 25\u201329 30\u201334 35\u201339 40\u201344 45\u201349 50\u201354 55\u201359 60\u201364 65\u201369 70\u201374 75\u201379 80\u201384 >85 Age, years Age, years Ca lung, trachea, bronhus"
        },
        {
            "id": "InternalMed_Harrison_31624",
            "title": "InternalMed_Harrison",
            "content": "Classification of Diseases (ICD-10), which is used more com monly worldwide, have taken somewhat differing approaches to the diagnosis of mental illness, but considerable effort has been expended to provide an operational translation between the two nosologies. Both systems are in essence purely descriptive and emphasize clinical pragmatism, in distinction to the Research Domain Criteria (RDOC) proposed by National Institute of Mental Health, which aspires to provide a causal framework for classification of behavioral disturbance. None of these diagnostic systems has as yet achieved adequate validation. The Global Burden of Disease Study 2010, using available epidemiologic data, nevertheless has reinforced the conclusion that, regardless of nosologic differences, mental and substance abuse disorders are the major cause of life-years lost to disability among all medical illnesses. There is general agreement that high-income countries will need to build capacity in professional training"
        },
        {
            "id": "Neurology_Adams_12155",
            "title": "Neurology_Adams",
            "content": "The prevalence of bipolar disease cannot be stated with precision, mainly because of varying criteria used for diagnosis. Certainly depression and depressive episodes are ubiquitous and mania is less common. The apparent increase of the disease in the past 50 years probably reflects a growing awareness of the condition among both physicians and the laity. Studies of large groups of patients from relatively isolated areas of Iceland and the Danish islands of Bornholm and Sams\u00d8 indicated that 5 percent of men and 9 percent of women developed symptoms of major depression, mania, or both at some time during their lives (Goodwin and Guze). More recent studies, such as the one conducted by the National Comorbidity Survey, report lifetime prevalence for bipolar disorder in the United States as 4.5 percent (Merikangas et al). According to the Global Burden of Disease Study, the incidence of bipolar disease increased by about 50 percent between 1990 and 2013 but it is still considered rare by"
        },
        {
            "id": "InternalMed_Harrison_19226",
            "title": "InternalMed_Harrison",
            "content": "States, approximately 525,000 patients experience a new AMI, and 190,000 experience a recurrent AMI each year. More than half of AMI-related deaths occur before the stricken individual reaches the hospital. The in-hospital mortality rate after admission for AMI has declined from 10% to about 6% over the past decade. The 1-year mortality rate after AMI is about 15%. Mortality is approximately fourfold higher in elderly patients (over age 75) as compared with younger patients."
        },
        {
            "id": "InternalMed_Harrison_10199",
            "title": "InternalMed_Harrison",
            "content": "Prognosis VAP is associated with significant mortality. Crude mortality rates of 50\u201370% have been reported, but the real issue is attributable mortality. Many patients with VAP have underlying diseases that would result in death even if VAP did not occur. Attributable mortality exceeded 25% in one matched-cohort study, while more recent studies have suggested much lower rates. Patients who develop VAP are at least twice as likely to die as those who do not. Some of the variability in VAP mortality rates is clearly related to the type of patient and ICU studied. VAP in trauma patients is not associated with attributable mortality, possibly because many of the patients were otherwise healthy before being injured. However, the causative pathogen also plays a major role. Generally, MDR pathogens are associated with significantly greater attributable mortality than non-MDR pathogens. Pneumonia caused by some pathogens (e.g., S. maltophilia) is simply a marker for a patient whose immune"
        },
        {
            "id": "InternalMed_Harrison_648",
            "title": "InternalMed_Harrison",
            "content": "Number of Deaths Among People Cause of Death Number of Deaths Percentage of Total \u226565 Years of Age Number of Deaths Percentage of Total All deaths Heart disease Malignant neoplasms Chronic lower respiratory diseases Cerebrovascular diseases Accidents Alzheimer\u2019s disease Diabetes mellitus Nephritis, nephritic syndrome, 2,468,435 100 1,798,276 499,331 100 597,689 24.2 477,338 141,362 28.3 574,743 23.3 396,670 142,107 28.5 138,080 5.6 118,031 27,132 5.4 129,476 5.2 109,990 35,846 7.2 120,859 4.9 41,300 11,256 2.3 83,494 3.4 82,616 8859 1.8 69,071 2.8 49,191 4931 1.0 50,476 2.0 41,994 4102 0.8 50,097 2.0 42,846 26,138 5.2 38,364 1.6 6008 3671 0.7 Source: National Center for Health Statistics (data for all age groups from 2010), http://www.cdc.gov/nchs; National Statistics (England and Wales, 2012), http://www.statistics.gov.uk."
        },
        {
            "id": "InternalMed_Harrison_940",
            "title": "InternalMed_Harrison",
            "content": "CHAPTER 12e The Safety and Quality of Health Care the use of a computerized ADE monitor, a tool that explores the database and identifies signals that suggest an ADE may have occurred. Studies that use multiple approaches find more ADEs than does any individual approach, and this discrepancy suggests that the true underlying rate in the population is higher than would be identified by a single approach. About 6\u201310% of patients admitted to U.S. hospitals experience an ADE. Injuries caused by drugs are also common in the outpatient setting. One study found a rate of 21 ADEs per every 100 patients per year when patients were called to assess whether they had had a problem with one of their medications. The severity level was lower than in the inpatient setting, but approximately one-third of these ADEs were preventable."
        },
        {
            "id": "Psichiatry_DSM-5_91",
            "title": "Psichiatry_DSM-5",
            "content": "Reliable diagnoses are essential for guiding treatment recommendations, identifying prevalence rates for mental health service planning, identifying patient groups for clinical and basic research, and documenting important public health information such as mor\u2014 bidity and mortality rates. As the understanding of mental disorders and their treatments has evolved, medical, scientific, and clinical professionals have focused on the character- istics of specific disorders and their implications for treatment and research."
        },
        {
            "id": "InternalMed_Harrison_937",
            "title": "InternalMed_Harrison",
            "content": "The Frequency of Adverse Events in Health Care Most large studies focusing on the frequency and consequences of adverse events have been performed in the inpatient setting; some data are available for nursing homes, but much less information is available about the outpatient setting. The Harvard Medical Practice Study, one of the largest studies to address this issue, was performed with hospitalized patients in New York. The primary outcome was the adverse event: an injury caused by medical management rather than by the patient\u2019s underlying disease. In this study, an event either resulted in death or disability at discharge or prolonged the length of hospital stay by at least 2 days. Key findings were that the adverse event rate was 3.7% and that 58% of the adverse events were considered preventable. Although New York is not representative of the United States as a whole, the study was replicated later in Colorado and Utah, where the rates were essentially similar. Since then, other"
        },
        {
            "id": "Surgery_Schwartz_7929",
            "title": "Surgery_Schwartz",
            "content": "the data is varied and complex to interpret.276 The Utah mortality study showed a 58% increase in all non\u2013disease-related causes of death in the RYGB group compared to the matched control population, including a small but significant increase in suicides, accidents, and intentional poisonings.202 Similar findings were observed in the second Utah Obesity Study.203 An observational study using Pennsylvania state data found that suicide rates were 13.7 per 10,000 among men and 5.2 per 10,000 among women among postbariatric surgery patients in Pennsylvania over 10 years, which were both significantly higher than age and sex-matched rates in the United States. In addition, the majority (70%) of these deaths occurred in the first 3 years following surgery when clinical follow-up is incomplete.277Finally, there is evidence that vitamin and micronutrient deficiencies are common following bariatric surgery including calcium, vitamin D, iron, zinc, and copper, and others. Guide-lines suggest"
        },
        {
            "id": "InternalMed_Harrison_5867",
            "title": "InternalMed_Harrison",
            "content": "61% for the 2003\u20132009 interval; however, the racial differences are narrowing over time. Incidence and mortality vary among racial and ethnic groups (Table 99-3). The basis for these differences is unclear."
        },
        {
            "id": "Neurology_Adams_27",
            "title": "Neurology_Adams",
            "content": "Donaghy and colleagues have provided a more detailed listing of the incidence of various neurologic diseases that are likely to be seen in the outpatient setting by a physician practicing in the United Kingdom. They note stroke as far and away the most commonly encountered condition. More focused surveys, such as the one conducted by Hirtz and colleagues, give similar rates of prevalence, with migraine, epilepsy, and multiple sclerosis being the most common neurologic disease in the general population (121, 7.1, and 0.9 per 1,000 persons in a year); stroke, traumatic brain injury, and spinal injury occurring in 183, 101, and 4.5 per 100,000 per year; and Alzheimer disease, Parkinson disease, and amyotrophic lateral sclerosis (ALS) among older individuals at rates of 67, 9.5, and 1.6 per 100,000 yearly. Data such as these assist in allocating societal resources, and they may be helpful in leading the physician to the correct diagnosis insofar as they emphasize the oft-stated dictum"
        },
        {
            "id": "Surgery_Schwartz_7902",
            "title": "Surgery_Schwartz",
            "content": "hyper-tension, 73% for T2DM, and 65% for hyperlipidemia. Results from 12 cohort-matched, nonrandomized studies comparing bariatric surgery vs. nonsurgical controls demonstrated reduced cardiovascular events and death (30\u201388% reduction) in patients with and without T2DM.227 One of these studies involving male veterans, who were mostly at high cardiovascular risk, reported a 42% reduction in mortality at 10 years compared with medical therapy.207 Similarly, in the Swedish Obese Subjects study, the mortality rate from cardiovascular disease in the bariatric surgical group was lower than for control patients (adjusted hazard ratio, 0.47; P = .002).201 For patients with T2DM in this study, surgery was associated with a 50% reduction in microvascular complica-tions (41.8 per 1000 person-years for control patients and 20.6 per 1000 person-years in the surgery group; hazard ratio, 0.44; P <.001).245 These observational, nonrandomized studies provide evidence that metabolic surgery is superior"
        },
        {
            "id": "Surgery_Schwartz_9672",
            "title": "Surgery_Schwartz",
            "content": "patients who suc-cessfully discontinued drinking, but in only 26% who did not.194The long-term survival of patients with chronic pancreatitis is less than for patients without pancreatitis. In an international multicenter study of >2000 patients, Lowenfels and colleagues found that the 10and 20-year survival rates for patients with chronic pancreatitis were 70% and 45%, respectively, compared to 93% and 65% for patients without pancreatitis.195 The mortality risk was found to be 1.6-fold higher in patients who continued to abuse alcohol, compared to those who did not. Continued alcohol abuse has a similar effect on the response to surgical treatment (Fig. 33-36), and results in a twofold increase in mortality over a 10to 14-year follow-up period.195In addition to progressive endocrine and exocrine dysfunc-tion, and the risk of the specific complications outlined here and in Table 33-16, the other significant long-term risk for the patient with chronic pancreatitis is the development"
        },
        {
            "id": "InternalMed_Harrison_31620",
            "title": "InternalMed_Harrison",
            "content": "Changes in health care delivery underscore the need for primary care physicians to assume responsibility for the initial diagnosis and treatment of the most common mental disorders. Prompt diagnosis is essential to ensure that patients have access to appropriate medical services and to maximize the clinical outcome. Validated patient-based questionnaires have been developed that systematically probe for signs and symptoms associated with the most prevalent psychiatric diagnoses and guide the clinician into targeted assessment. The Primary Care Evaluation of Mental Disorders (PRIME-MD; and a self-report form, the Patient Health Questionnaire) and the Symptom-Driven Diagnostic System for Primary Care (SDDS-PC) are inventories that require only 10 min to complete and link patient responses to the formal diagnostic criteria of anxiety, mood, somatoform, and eating disorders and to alcohol abuse or dependence."
        },
        {
            "id": "InternalMed_Harrison_5983",
            "title": "InternalMed_Harrison",
            "content": "Assessment of Screening Tests Good clinical trial design can offset some biases of screening and demonstrate the relative risks and benefits of a screening test. A randomized controlled screening trial with cause-specific mortality as the endpoint provides the strongest support for a screening intervention. Overall mortality should also be reported to detect an adverse effect of screening and treatment on other disease outcomes (e.g., cardiovascular disease). In a randomized trial, two like populations are randomly established. One is given the usual standard of care (which may be no screening at all) and the other receives the screening intervention being assessed. The two populations are compared over time. Efficacy for the population studied is established when the group receiving the screening test has a better cause-specific mortality rate than the control group. Studies showing a reduction in the incidence of advanced-stage disease, improved survival, or a stage shift are weaker"
        },
        {
            "id": "Gynecology_Novak_1051",
            "title": "Gynecology_Novak",
            "content": "The absolute risk of deep vein thrombosis was strongly in\ufb02uenced by age, increasing from 1.84 per 10,000 women aged 15 to 19 years to 6.59 per 10,000 for women aged 45 to 49 years with current users, former users, and never users combined. With all types of OCs combined, the overall absolute rate of deep vein thrombosis was 6.29 per 10,000 woman-years for current OC users compared to 3.01 among nonusers, giving an adjusted rate ratio of 2.83 (95% confidence interval [CI], 2.65\u20133.01) (Table 10.6). This is a higher absolute risk than the 3 per 10,000 woman-years previously estimated and may re\ufb02ect, among other things, the use of better means for diagnosis of deep vein thrombosis (131). This population-based study includes all Danish women aged 15 to 49, excluding only women with a diagnosis of cancer or of cardiovascular disease diagnosed before the study interval. Thrombosis risk was highest during the first year of use and decreased thereafter (Table 10.6)."
        },
        {
            "id": "Surgery_Schwartz_5272",
            "title": "Surgery_Schwartz",
            "content": "Last 4 Years (January 2012\u2013December 2015)Figure 20-70. Program performance as currently reported by the STS-CHSD.Brunicardi_Ch20_p0751-p0800.indd 79222/02/19 2:57 PM 793CONGENITAL HEART DISEASECHAPTER 20mortality (the 95% confidence interval for their risk-adjusted O/E mortality ratio was entirely above the number 1), two stars equals the same as expected operative mortality (the 95% con-fidence interval for their risk-adjusted O/E mortality ratio over-lapped with the number 1), and three stars equals lower than expected operative mortality (the 95% confidence interval for their risk-adjusted O/E mortality ratio was entirely below the number 1). The Spring 2016 STS CHSD Feedback Report includes data from 117 participants in the STS-CHSD, including 14 one-star programs, 83 two-star programs, and 8 three-star programs. Twelve participants did not receive a star rating due to incomplete data.191 Public reporting increased from 23% to 57.6% (all three-star programs, 50 two-star and"
        },
        {
            "id": "Neurology_Adams_6642",
            "title": "Neurology_Adams",
            "content": "A comprehensive and still instructive, but now dated, long-term analysis of the natural history of the disease is contained in the report of the Cooperative Study of Intracranial Aneurysms and Subarachnoid Hemorrhage (Sahs et al, 1984). The study was based on long-term observations of 568 patients who sustained an aneurysmal bleed between 1958 and 1965 and were managed only by a conservative medical program. A followup search in 1981 and 1982 disclosed that 378, or two-thirds of the patients, had died; 40 percent of the deaths had occurred within 6 months of the original hemorrhage. For the patients who survived the original hemorrhage for 6 months, the chances of survival during the next two decades were significantly worse than those of a matched normal population. Rebleeding occurred at a rate of 2.2 percent per year during the first decade and 0.86 percent per year during the second, and these were fatal in 78 percent of cases. Although these statistics reflect the outcome prior"
        },
        {
            "id": "InternalMed_Harrison_6709",
            "title": "InternalMed_Harrison",
            "content": "screening trial received annual CXR screening for 4 years, whereas participants in the usual care group received no interventions other than their customary medical care. The diagnostic follow-up of positive screening results was determined by participants and their physicians. The PLCO trial differed from previous lung cancer screening studies in that women and never smokers were eligible. The study was designed to detect a 10% reduction in lung cancer mortality in the interventional group. A total of 154,901 individuals between 55 and 74 years of age were enrolled (77,445 assigned to annual CXR screenings; 77,456 assigned to usual care). Participant demographics and tumor characteristics were well balanced between the two groups. Through 13 years of follow-up, cumulative lung cancer incidence rates (20.1 vs 19.2 per 10,000 person-years; rate ratio [RR], 1.05; 95% confidence interval [CI], 0.98\u20131.12) and lung cancer mortality (n = 1213 vs n = 1230) were identical between the two"
        },
        {
            "id": "First_Aid_Step2_227",
            "title": "First_Aid_Step2",
            "content": "Odds that a diseased person is exposed Odds ratio = Odds that a nondiseased person is exposed Odds ratio: (odds that injured staff used scissors) \u00f7 (odds that uninjured staff used scissors). Once a diagnosis has been established, it is important to be able to describe the associated prognosis. Survival analysis is used to summarize the average time from one event (e.g., presentation, diagnosis, or start of treatment) to any outcome that can occur only once during follow-up (e.g., death or recurrence of cancer). The usual method is with a Kaplan-Meier curve (see Figure 2.4-3) describing the survival (or time-to-event if the measured outcome is not death) in a cohort of patients, with the probability of survival de Probability of event creasing over time as patients die or drop out (are censored) from the study. Odds = 1 \u2212 probability of"
        },
        {
            "id": "InternalMed_Harrison_825",
            "title": "InternalMed_Harrison",
            "content": "FIgURE 11-12 Longitudinal trajectory of bioavailable testosterone plasma concentration in the Baltimore Longitudinal Study of Aging (BLSA). The plot is based on 584 men who were 50 years or older with a total of 1455 data points. The average follow up for each subject was 3.2 years. (Figure created using unpublished data from the BLSA.) energy for compensatory mechanisms. Indeed, observational studies have demonstrated (1) that older persons with poor health status and substantial morbidity have a higher RMR than healthier individuals of the same age and sex and (2) that a high RMR is an independent risk factor for mortality and may contribute to the weight loss that often accompanies severe illness. Finally, for reasons that are not yet completely clear but certainly involve changes in the biomechanical characteristics of movement, older age, pathology, and physical impairment increase the energy cost of motor activities such as walking. Overall, older individuals with multiple"
        }
    ],
    "scores": [
        0.02601974647005985,
        0.02532125309829708,
        0.02467928227421898,
        0.023881742104941664,
        0.0234850080037313,
        0.019419306184012067,
        0.018499573742540493,
        0.017721320473614053,
        0.017582753612109165,
        0.017147366910604103,
        0.01709773237701949,
        0.016928571428571428,
        0.01628707627118644,
        0.016095669036845506,
        0.016078164615670028,
        0.015839300886029858,
        0.01576530235748113,
        0.01568844592100406,
        0.015542521994134896,
        0.015306395504415307,
        0.015173285821024196,
        0.015016872890888638,
        0.014818067065473903,
        0.014814814814814815,
        0.014648033126293996,
        0.01460046384145056,
        0.014484126984126985,
        0.014134452102687045,
        0.013877207737594618,
        0.013654362568840745,
        0.013568935427574171,
        0.013400988810824875
    ]
}